Pharmaceutical Companies Back U.K. Dementia Discovery Fund To Research Diagnoses, Treatments

Financial Times: Pharma groups join U.K. in $100m dementia fund
“A $100m dementia research fund has been launched with backing from the British government and several of the world’s biggest pharmaceuticals groups to hunt for new ways to diagnose and treat the disease. The Dementia Discovery Fund is one of the most concrete steps to come out of efforts by David Cameron, U.K. prime minister, to lead what he has described as a ‘global fightback’ against Alzheimer’s disease and similar conditions…” (Ward, 10/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.